Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,017
  • Shares Outstanding, K 41,845
  • Annual Sales, $ 19,630 K
  • Annual Income, $ -60,480 K
  • EBIT $ 11 M
  • EBITDA $ 14 M
  • 60-Month Beta 1.90
  • Price/Sales 0.10
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.73
  • Most Recent Earnings $1.07 on 11/12/25
  • Next Earnings Date 02/11/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +370,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0361 +33.52%
on 11/21/25
0.1000 -51.80%
on 12/10/25
-0.0025 (-4.93%)
since 11/19/25
3-Month
0.0261 +84.67%
on 10/15/25
0.3075 -84.33%
on 09/23/25
-0.2019 (-80.73%)
since 09/19/25
52-Week
0.0261 +84.67%
on 10/15/25
1.2700 -96.20%
on 06/10/25
-0.3933 (-89.08%)
since 12/19/24

Most Recent Stories

More News
Carisma Announces Delisting from Nasdaq and SEC Deregistration

PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends...

CARM : 0.0482 (-7.13%)
Carisma Therapeutics Faces Nasdaq Delisting and Trading Suspension

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Carisma Therapeutics...

CARM : 0.0482 (-7.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders

NEW YORK , July 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CARM : 0.0482 (-7.13%)
HLGN : 1.7000 (+2.10%)
NVEE : 22.56 (+0.49%)
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases

CARM : 0.0482 (-7.13%)
OCGN : 1.4000 (-2.78%)
Carisma Therapeutics to Present at Upcoming Investor Conferences

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 0.0482 (-7.13%)
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 0.0482 (-7.13%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 0.0482 (-7.13%)
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 0.0482 (-7.13%)
Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 0.0482 (-7.13%)
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma Therapeutics" or the "Company"), a clinical stage biopharmaceutical company focused on...

CARM : 0.0482 (-7.13%)

Business Summary

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in...

See More

Key Turning Points

3rd Resistance Point 0.0657
2nd Resistance Point 0.0599
1st Resistance Point 0.0540
Last Price 0.0482
1st Support Level 0.0423
2nd Support Level 0.0365
3rd Support Level 0.0306

See More

52-Week High 1.2700
Fibonacci 61.8% 0.7948
Fibonacci 50% 0.6481
Fibonacci 38.2% 0.5013
Last Price 0.0482
52-Week Low 0.0261

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar